Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 28.03x is in line with its estimated 1-year average of 28.85x, around the middle of its estimated 1-year range (26.90x–30.44x).
As of 2026-10-06T16:57:23.870Z.
Calculation as of: 2026-10-06T16:57:23.870Z.
Quote observation: 2026-10-06T16:55:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 757805bafeebc6dd018a704dcae2ac70006cc574d7bdbc7e38b059e75a8ad8a2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
28.03x
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.75x
median of 205 covered companies
CURRENT VS SECTOR MEDIAN
+77.97%
vs the sector median at left
Lumexa Imaging Holdings, Inc. Common Stock
Market Cap
$1.03B
EV/EBITDA Ratio
28.03x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.03B
EV/EBITDA Ratio
N/A
TTM Avg
56.92x
3Y Avg
58.14x
5Y Avg
58.14x
Market Cap
$1.04B
EV/EBITDA Ratio
N/A
TTM Avg
2.11x
3Y Avg
2.11x
5Y Avg
2.11x
Market Cap
$1.04B
EV/EBITDA Ratio
3.54x
TTM Avg
9.11x
3Y Avg
16.07x
5Y Avg
16.78x
Market Cap
$1.00B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$990.75M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.06B
EV/EBITDA Ratio
12.99x
TTM Avg
29.00x
3Y Avg
192.84x
5Y Avg
192.84x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $1.03B | 28.03x | N/A | N/A | N/A |
| Immatics N.V. (IMTX)vs › | $1.03B | N/A | 21.42x | 21.42x | 21.42x |
| Castle Biosciences, Inc. (CSTL)vs › | $1.03B | N/A | 56.92x | 58.14x | 58.14x |
| Janux Therapeutics, Inc. (JANX)vs › | $1.03B | N/A | N/A | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.04B | N/A | 2.11x | 2.11x | 2.11x |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.04B | 3.54x | 9.11x | 16.07x | 16.78x |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $990.75M | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.06B | 12.99x | 29.00x | 192.84x | 192.84x |
| Pacira BioSciences, Inc. (PCRX)vs › | $983.38M | 11.48x | 10.94x | 46.55x | 35.86x |
At 28.0, EV/EBITDA is below its estimated 1-year median — higher than 28% of readings in its estimated 1-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 1-year low
26.9
median
29.2
estimated 1-year high
30.4
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-10-05 | 28.14x |
| 2026-10-02 | 27.51x |
| 2026-10-01 | 27.21x |
| 2026-09-30 | 27.41x |
| 2026-09-29 | 27.43x |
| 2026-09-28 | 27.28x |
| 2026-09-25 | 27.36x |
| 2026-09-24 | 26.90x |
| 2026-09-23 | 27.26x |
| 2026-09-22 | 27.79x |
| 2026-09-21 | 28.01x |
| 2026-09-18 | 28.57x |
| 2026-09-17 | 29.18x |
| 2026-09-16 | 29.36x |
| 2026-09-15 | 29.53x |
| 2026-09-14 | 29.00x |
| 2026-09-11 | 29.14x |
| 2026-09-10 | 28.72x |
| 2026-09-09 | 28.85x |
| 2026-09-08 | 29.21x |
| 2026-09-04 | 30.10x |
| 2026-09-03 | 29.71x |
| 2026-09-02 | 29.50x |
| 2026-09-01 | 29.35x |
| 2026-08-31 | 29.39x |
| 2026-08-28 | 29.17x |
| 2026-08-27 | 29.48x |
| 2026-08-26 | 29.80x |
| 2026-08-25 | 29.95x |
| 2026-08-24 | 29.64x |
| 2026-08-21 | 30.44x |
| 2026-08-20 | 29.41x |
| 2026-08-19 | 29.64x |
| 2026-08-18 | 29.84x |
| 2026-08-17 | 29.59x |
| 2026-08-14 | 29.88x |